Formulation meets function: addressing palatability in drug development (part II)

Published: 29-Sep-2025

Part I of this article examined the critical role of palatability in patient adherence to treatment regimens, the underlying biological challenges of bitterness in medications and the innovative strategies used to create more acceptable and effective drug formulations

You need to be a subscriber to read this article.
Click here to find out more.

A further challenge to overcome is that the perception of bitterness varies from one individual to another.

Even in today’s age of sophisticated technology, there is still no substitute for human insights, making access to sensory experts who are trained to quantify the intensity of bitterness in different pharmaceutical products vital.

Sensory panellists — usually 8–10 people but sometimes a much larger group — are carefully selected based on their sensitivity to bitterness.

They undergo rigorous training using a well-defined and stringent tasting protocol to ensure consistent and objective assessments and safe working practices when evaluating products containing APIs.11

Standardised scales are used to rate bitterness intensity, enabling reliable comparisons across different formulations to help gauge how they will perform in the market.

The integration of one or more of these approaches enables formulators to benefit from solutions that allow the production of effective, more palatable products, driving better patient adherence to treatment regimens. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like